The stock's rise snapped a three-day losing streak.

This was the stock's third consecutive day of losses.

West Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and sustained strength in research and development (R&D). However, foreign exchange ...

West Pharmaceutical Services (NYSE:WST – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday.

Pacer Advisors Inc. decreased its position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 33.1% during the 4th quarter, according to its most recent filing with the Securities and ...

"West launches Daikyo PLASCAP RUV closures in new nested format" was originally created and published by Packaging Gateway, a ...

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East ...

EXTON, Pa., Jan. 30, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will ...

West Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and sustained strength in research and development (R&D). However, foreign ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.